| Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
|---|---|---|---|---|---|
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 0.6148 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 0.6853 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 0.849 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.0571 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.0656 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.4185 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.6424 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.7474 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.8026 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.9056 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 1.998 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 2.0076 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 2.1363 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 2.2246 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | gamma-glutamylleucine | 2.7915 | VolNormImp Area counts | db/db | ZT17 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|